QIAGEN N.V. (QGEN) Form 6-K — Nov 5, 2026
QIAGEN disclosed that on October 21, 2026 it entered a Business Combination Agreement under which Crown NL Bidco B.V., a holding company controlled by EQT XI fund (EQT Private Equity), will make an all-cash voluntary public takeover offer for all outstanding QIAGEN shares at €46.50 per share. Both QIAGEN boards unanimously approved the deal, which values the company at approximately €10.8 billion enterprise value (~$12.1 billion including ~$1.1 billion net debt). The offer remains subject to regulatory approvals, an Extraordinary General Meeting shareholder vote, and board decisions on post-closing measures, so closing is not yet assured.
Key figures
- Eps
- 0.51
- Revenue
- 547869000
- Net Income
- 105659000
- Total Debt
- 1642855000
- Revenue Yoy
- +3% (Q3 2026 vs Q3 2025); +2% nine months
- Total Assets
- 5942470000
- Cash Position
- 805132000
- Deal Value Usd
- $12.1 billion (approximately €10.8 billion enterprise value)
- Q3 gross margin
- 64.6%
- Nine month revenue
- $1,575.2 million
- Offer price per share
- €46.50
- Q3 effective tax rate
- 20.1% vs 3.5% prior year
- Net debt in deal value
- $1.1 billion
- Diluted eps nine months
- $1.33
- Operating cash flow nine months
- $446.9 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.